Robust experiment design for estimating myocardial β adrenergic receptor concentration using PET

Medical Physics

Volumn 34, Issue 1, 2007, Pages 151-165

  Salinas, Cristian ^a   Muzic, Raymond F ^a   Ernsberger, Paul ^b   Saidel, Gerald M ^a  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Fluorocarazolol; Optimal experiment design; Positron emission tomography; adrenergic receptors

Indexed keywords

DESIGN; LIGANDS; OPTIMIZATION; PATHOLOGY; PHYSIOLOGICAL MODELS; POSITRONS;

ADRENERGIC RECEPTORS; CONGESTIVE HEART FAILURES; EXPERIMENT DESIGN; FLUOROCARAZOLOL; HETEROGENEOUS POPULATIONS; OPTIMAL DESIGN; OPTIMAL EXPERIMENT DESIGN; RELIABLE ESTIMATES; SYNTHETIC POPULATIONS; Β ADRENERGIC RECEPTOR;

POSITRON EMISSION TOMOGRAPHY;

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUOROCARAZOLOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL SYMPATHECTOMY; CLINICAL PROTOCOL; COMPUTER AIDED DESIGN; CONTROLLED STUDY; EXPERIMENTAL DESIGN; HEART MUSCLE; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; NONHUMAN; PATHOLOGY; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SWINE; UPREGULATION;

SUS SCROFA;

EID: 33845919225     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2402585     Document Type: Article

References (53)

1. M. R. Bristow, R. Ginsburg, W. Minobe, R. S. Cubicciotti, W. S. Sageman, K. Lurie, M. E. Billingham, D. C. Harrison, and E. B. Stinson, " Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts., " N. Engl. J. Med. 307, 205-211 (1982).
2. M. R. Bristow, " Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy., " Circulation 84, 1024-1039 (1991).
3. O. E. Brodde, " Beta-adrenoceptors in cardiac disease., " Pharmacol. Ther. 60, 405-430 (1993).
4. O. E. Brodde, " Beta 1- and beta 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure [published erratum appears in Pharmacol. Rev. 1991 Sep; 43(3), 350]., " Pharmacol. Rev. 43, 203-242 (1991).
5. E. Plante, D. Lachance, M. Gaudreau, M. C. Drolet, E. Roussel, M. Arsenault, and J. Couet, " Effectiveness of beta-blockade in experimental chronic aortic regurgitation., " Circulation 110, 1477-1483 (2004).
6. X. Wang, B. Ren, S. Liu, E. Sentex, P. S. Tappia, and N. S. Dhalla, " Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat., " J. Appl. Physiol. 94, 752-763 (2003).
7. X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla, " Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload., " Am. J. Physiol. Heart Circ. Physiol. (2005).
8. M. R. Chester, B. Madden, D. Barnett, and M. Yacoub, " The effect of orthotopic transplantation on total, beta 1- and beta 2-adrenoceptors in the human heart., " Br. J. Clin. Pharmacol. 33, 417-422 (1992).
9. K. G. Lurie, M. R. Bristow, and B. A. Reitz, " Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation., " J. Thorac. Cardiovasc. Surg. 86, 195-201 (1983).
10. R. M. de Jong, P. K. Blanksma, W. A. van, and D. J. van Veldhuisen, " Measurement of myocardial beta-adrenoceptor density in clinical studies: a role for positron emission tomography?, " Eur. J. Nucl. Med. Mol. Imaging 29, 88-97 (2002).
11. P. Doze, A. van Waarde, P. H. Elsinga, W. Van-Loenen, A. T. Willemsen, and W. Vaalburg, " Validation of S- 1′ -[18F]fluorocarazolol for in vivo imaging and quantification of cerebral beta-adrenoceptors., " Eur. J. Pharmacol. 353, 215-226 (1998).
12. R. F. Muzic, Jr., A. D. Nelson, G. M. Saidel, and F. Miraldi, " Optimal experiment design for PET quantification of receptor concentration., " IEEE Trans. Med. Imaging 15, 2-12 (1996).
13. A. van Waarde, T. J. Visser, P. H. Elsinga, B. de Jong, T. W. van der Mark, J. Kraan, K. Ensing, J. Pruim, A. T. Willemsen, O. E. Brodde, G. M. Visser, A. M. Paans, and W. Vaalburg, " Imaging beta-adrenoceptors in the human brain with (S)- 1′ [F18] fluorocarazolol., " J. Nucl. Med. 38, 934-939 (1997).
14. T. I. Visser, A. van Waarde, T. W. van der Mark, J. Kraan, P. H. Elsinga, J. Pruim, K. Ensing, T. Jansen, A. T. Willemsen, E. J. Franssen, G. M. Visser, A. M. Paans, and W. Vaalburg, " Characterization of pulmonary and myocardial beta-adrenoceptors with S- 1′ -[fluorine-18]fluorocarazolol., " J. Nucl. Med. 38, 169-174 (1997).
15. M. J. Hayes, F. Qing, C. G. Rhodes, S. U. Rahman, P. W. Ind, S. Sriskandan, T. Jones, and J. M. Hughes, " In vivo quantification of human pulmonary beta-adrenoceptors: Effect of beta-agonist therapy., " Am. J. Respir. Crit. Care Med. 154, 1277-1283 (1996).
16. P. Merlet, J. Delforge, A. Syrota, E. Angevin, B. Maziere, C. Crouzel, H. Valette, D. Loisance, A. Castaigne, and J. L. Rande, " Positron emission tomography with C11 CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy [see comments]., " Circulation 87, 1169-1178 (1993).
17. F. Qing, C. G. Rhodes, M. J. Hayes, T. Krausz, S. W. Fountain, T. Jones, and J. M. Hughes, " In vivo quantification of human pulmonary beta-adrenoceptor density using PET: Comparison with in vitro radioligand binding., " J. Nucl. Med. 37, 1275-1281 (1996).
18. J. Ueki, C. G. Rhodes, J. M. Hughes, R. De Silva, D. C. Lefroy, P. W. Ind, F. Qing, F. Brady, S. K. Luthra, and C. J. Steel, " In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET., " J. Appl. Physiol. 75, 559-565 (1993).
19. R. F. J. Muzic, G. M. Saidel, N. Zhu, A. D. Nelson, L. Zheng, and M. S. Berridge, " Iterative optimal design of PET experiments for estimating β -adrenergic receptor concentration., " Med. Biol. Eng. Comput. 38, 593-602 (2000).
20. R. F. Muzic, Jr., M. S. Berridge, L. Zheng, A. D. Nelson, and F. Miraldi, " PET measurement of beta-adrenergic receptor concentration using [F-18]Fluorocarazolol., " 37, 174 (1966).
21. J. Delforge, D. Mesangeau, F. Dolle, P. Merlet, C. Loc'h, M. Bottlaender, R. Trebossen, and A. Syrota, " In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density., " J. Nucl. Med. 43, 215-226 (2002).
22. B. T. Christian, T. K. Narayanan, B. Shi, and J. Mukherjee, " Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates., " Synapse 38, 71-79 (2000).
23. B. T. Christian, T. Narayanan, B. Shi, E. D. Morris, J. Mantil, and J. Mukherjee, " Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol., " J. Cereb. Blood Flow Metab. 24, 309-322 (2004).
24. E. D. Morris, J. W. Babich, N. M. Alpert, A. A. Bonab, E. Livni, S. Weise, H. Hsu, B. T. Christian, B. K. Madras, and A. J. Fischman, " Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT., " Synapse 24, 262-272 (1996).
25. J. Delforge, C. Loc'h, P. Hantraye, O. Stulzaft, M. Khalili-Varasteh, M. Maziere, A. Syrota, and B. Maziere, " Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET., " J. Cereb. Blood Flow Metab. 11, 914-925 (1991).
26. M. A. Mintun, M. E. Raichle, M. R. Kilbourn, G. F. Wooten, and M. J. Welch, " A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography., " Ann. Neurol. 15, 217-227 (1984).
27. J. Delforge, A. Syrota, and B. M. Mazoyer, " Experimental design optimisation: Theory and application to estimation of receptor model parameters using dynamic positron emission tomography., " Phys. Med. Biol. 34, 419-435 (1989).
28. M. S. Berridge, A. D. Nelson, L. Zheng, G. P. Leisure, and F. Miraldi, " Specific beta-adrenergic receptor binding of carazolol measured with PET., " J. Nucl. Med. 35, 1665-1676 (1994).
29. C. Salinas, R. F. Muzic, Jr., M. Berridge, and P. Ernsberger, " PET imaging of myocardial beta-adrenergic receptors with fluorocarazolol: Lack of interference by endogenous catecholamines., " J. Cardiovasc. Pharmacol. 46, 222-231 (2005).
30. L. Zheng, M. S. Berridge, and P. Ernsberger, " Synthesis, binding properties, and F18 labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist., " J. Med. Chem. 37, 3219-3230 (1994).
31. K. Wienhard, M. Dahlbom, L. Eriksson, C. Michel, T. Bruckbauer, U. Pietrzyk, and W. D. Heiss, " The ECAT EXACT HR: Performance of a new high resolution positron scanner., " J. Comput. Assist. Tomogr. 18, 110-118 (1994).
32. R. F. Muzic, Jr., A. D. Nelson, G. J. Muswick, W. Voelker, and F. Miraldi, " A device for continuous monitoring of arterial positron concentration using a gamma detector., " 29, 833 (1988).
33. C. A. Salinas, M. D. Pagel, and R. F. J. Muzic, " Measurement of arterial input functions in rats., " J. Soc. Mol. Imaging, 213-214 (2004).
34. R. F. Muzic, Jr., B. J. Landmeier, Z. Zhang, L. Zheng, and M. S. Berridge, " Solid-Phase analysis method for (S)- [F18] fluorocarazolol and its metabolites., " J. Chromatogr., B: Biomed. Appl. 759, 355-359 (2001).
35. H. Valette, P. Deleuze, A. Syrota, J. Delforge, C. Crouzel, C. Fuseau, and D. Loisance, " Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: A PET study [see comments]., " J. Nucl. Med. 36, 140-146 (1995).
36. J. Tse, E. Rodriquez, M. Gonzalez, and H. R. Weiss, " Effects of chemical denervation with 6-hydroxydopamine on myocardial responsiveness to isoproterenol in rabbits., " Basic Res. Cardiol. 90, 380-387 (1995).
37. N. Tumer, W. T. Houck, and J. Roberts, " Effect of age on upregulation of the cardiac adrenergic beta receptors., " J. Gerontol. 45, B48-B51 (1990).
38. H. J. Motulsky and L. A. Ransnas, " Fitting curves to data using nonlinear regression: A practical and nonmathematical review., " FASEB J. 1, 365-374 (1987).
39. K. Schittkowski, Numerical Optimization and Data Fitting in Dynamical Systems (Department of Mathematics, University of Bayreuth, Germany, 2000), 44-46.
40. I. The MathWorks, " Optimization Toolbox, Version 3.0.1., " (2004).
41. E. D. Morris, G. M. Saidel, and G. M. Chisolm, " Optimal design of experiments to estimate LDL transport parameters in arterial wall., " Am. J. Physiol. 261, H929-H949 (1991).
42. T. Stadler, W. Ebert, F. Kehlbach, E. Muller, and H. von Faber, " Beta-adrenergic receptors and adenylate cyclase activity in heart, muscle and adipose tissue of German Landrace pigs selectively bred for differences in backfat deposition., " Horm. Metab. Res. 22, 145-152 (1990).
43. O. H. Lowry, H. J. Rosebrough, A. L. Farr, and R. J. Randall, " Protein measurement with the Folin phenol reagent., " J. Biol. Chem. 193, 265-275 (1951).
44. J. Delforge, A. Syrota, J. P. Lancon, K. Nakajima, C. Loc'h, M. Janier, J. M. Vallois, J. Cayla, and C. Crouzel, " Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method [published erratum appears in J. Nucl. Med. 1994 May, 35(5), 921]., " J. Nucl. Med. 32, 739-748 (1991).
45. J. Delforge, D. Mesangeau, F. Dolle, P. Merlet, C. Loc'h, M. Bottlaender, R. Trebossen, and A. Syrota, " In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density., " J. Nucl. Med. 43, 215-226 (2002).
46. P. Doze, P. H. Elsinga, W. A. van, R. M. Pieterman, J. Pruim, W. Vaalburg, and A. T. Willemsen, " Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP 12388 and a tracer kinetic model., " Eur. J. Nucl. Med. Mol. Imaging 29, 295-304 (2002).
47. M. H. Burnam, D. H. Sethna, D. M. Rose, C. S. Stern, and W. E. Shell, " Differences in beta-adrenoceptor binding in anterior and inferior myocardial wall microsomes of normal canine left ventricle., " Cardiovasc. Res. 15, 239-244 (1981).
48. M. Ungerer, F. Hartmann, M. Karoglan, A. Chlistalla, S. Ziegler, G. Richardt, M. Overbeck, H. Meisner, A. Schomig, and M. Schwaiger, " Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart., " Circulation 97, 174-180 (1998).
49. R. M. de Jong, A. T. Willemsen, R. H. Slart, P. K. Blanksma, W. A. van, J. H. Cornel, W. Vaalburg, D. J. van Veldhuisen, and P. H. Elsinga, " Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388., " Eur. J. Nucl. Med. Mol. Imaging 32, 443-447 (2005).
50. D. C. Lefroy, " Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: A study with positron emission tomography., " J. Am. Coll. Cardiol. 22, 1653-1660 (1993).
51. R. M. de Jong, C. G. Rhodes, R. L. Anthonio, A. T. Willemsen, P. K. Blanksma, A. A. Lammertsma, S. D. Rosen, W. Vaalburg, H. J. Crijns, and P. G. Camici, " Parametric polar maps of regional myocardial beta-adrenoceptor density., " J. Nucl. Med. 40, 507-512 (1999).
52. Y. Bard, Nonlinear Parameter Estimation (Academic, New York, 1974).
53. J. R. Votaw, R. M. Kessler, and T. de Paulis, " Failure of the three compartment model to describe the pharmacokinetics in brain of a high affinity substituted benzamide., " Synapse 15, 177-190 (1993).